Avalon GloboCare Eliminates Majority of Debentures Through $2.6 Million Conversion, Strengthening Balance Sheet, Reduces Overhang
Stocks in this Quantisnow insightHealth Care
Historical context for ALBT
Across the 6 sessions after earlier ALBT headlines, the stock closed higher 1 times and lower 5 times, with a median move of 6.0% in either direction. This shows timing only: many things move a stock in a session, and these figures do not show that any headline caused a move.
| Session | Earlier headline | ALBT | SPY |
|---|---|---|---|
| Jan 22, 2026 | Avalon GloboCare's Subsidiary Files AI Patent Targeting Compliance-Ready Automated Video Commentary | +1.6% | +0.5% |
| Jan 20, 2026 | Avalon GloboCare Announces FDA Registration Renewal for KetoAir™ and Planned B2B and B2C Launch Through Catch-Up™, Its Automated Generative AI-Powered Short-Form Video SaaS Platform | -6.0% | -2.0% |
| Jan 12, 2026 | Avalon GloboCare Regains Compliance with Nasdaq Stockholders' Equity Requirement, Launches Marketing for Automated Generative AI Video Platform | -10.2% | +0.2% |
| Dec 30, 2025 | Avalon GloboCare Board Director Highlights RPM Interactive's Automated Generative AI Video Creation Platform in Interview with ProactiveInvestors.com | -6.0% | -0.1% |
| Dec 23, 2025 | E.F. Hutton Advises on RPM Interactive's Acquisition by Avalon GloboCare | -1.5% | +0.5% |
| Dec 1, 2025 | Avalon GloboCare Reports Q3 2025 Progress with KetoAir™, Holistic Health Initiatives, and International Expansion | -8.1% | -0.5% |
Keep researching ALBT
Quantisnow market dataNASDAQ
ALBT
Avalon GloboCare Corp.
- Market cap
- 30-day
- Sector
- Health Care
- Industry
- Biotechnology: Biological Products (No Diagnostic Substances)
Get push alerts for ALBT
Full ALBT profile on Quantisnow Follow ALBT and get a push notification the moment its next story breaks.